0.022121 0.000000 0.010851 0.000000 0.019398 0.000000 0.000000 0.000000 0.024474 0.00000 0.00000 0.00000 Brinen, L.S. Gillmor, S.A. Fletterick, R.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 2 90.00 116.13 90.00 45.206 51.551 45.511 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking C34 H36 N2 O6 S 600.724 N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER WRR-204 peptide-like To be Published 0353 Crystal Structure of Cruzain bound to WRR-204 University of California, San Francisco (THESIS) Enzyme-ligand Interactions, Inhibition and Specificity 50 80 Chapter 3: X-ray Structures of Complexes of Cruzain with Designed Covalent Inhibitors 1998 US Protein Sci. PRCIEI 0795 0961-8368 6 1603 1611 Structural Determinants of Specificity in the Cysteine Protease Cruzain 1997 UK J.Mol.Biol. JMOBAK 0070 0022-2836 247 251 259 10.1006/jmbi.1994.0137 The Crystal Structure of Cruzain: a Therapeutic Target for Chagas' Disease 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 298 1 IMAGE PLATE 1997-10-14 RIGAKU RAXIS IV SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RU200 22715.133 CRUZAIN 3.4.22.- CATALYTIC DOMAIN 1 man polymer 600.724 N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER 1 syn non-polymer 18.015 water 38 nat water CRUZIPAIN, cruzaine no no APAAVDWRARGAVTAVKDQGQCGSCWAFSAIGNVECQWFLAGHPLTNLSEQMLVSCDKTDSGCSGGLMNNAFEWIVQENN GAVYTEDSYPYASGEGISPPCTTSGHTVGATITGHVELPQDEAQIAAWLAVNGPVAVAVDASSWMTYTGGVMTSCVSEQL DHGVLLVGYNDSAAVPYWIIKNSWTTQWGEEGYIRIAKGSNQCLVKEEASSAVVG APAAVDWRARGAVTAVKDQGQCGSCWAFSAIGNVECQWFLAGHPLTNLSEQMLVSCDKTDSGCSGGLMNNAFEWIVQENN GAVYTEDSYPYASGEGISPPCTTSGHTVGATITGHVELPQDEAQIAAWLAVNGPVAVAVDASSWMTYTGGVMTSCVSEQL DHGVLLVGYNDSAAVPYWIIKNSWTTQWGEEGYIRIAKGSNQCLVKEEASSAVVG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Trypanosoma Escherichia sample 5693 Trypanosoma cruzi 562 Escherichia coli DH5ALPHA CHEY 1 2.10 41.29 VAPOR DIFFUSION, HANGING DROP 7.0 0.8M NaCitrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K 292 repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance 1 0 2003-06-10 1 1 2008-04-27 1 2 2011-07-13 same protein, ZYA inhibitor same protein, ZRA inhibitor same protein, WRR-99 inhibitor same protein, WRR-112 inhibitor same protein, MOR-LEU-HPQ inhibitor RCSB Y RCSB 2000-04-26 REL REL VSC N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER HOH water VSC WAS N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO- 5-PHENYL-PENT-1-ENE-1-SULFONIC ACID PHENYL ESTER BEFORE REACTION WITH THE PROTEASE. AFTER REACTION, THE SG OF CYS 25 IS LINKED TO C32 OF THE VSC 280, N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5- PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER. THE PHENYL RING ATTACHED TO ONE OXYGEN OF THE SULFONIC ACID PORTION OF THE LIGAND IS MISSING IN THE DENSITY. THERE IS A STOP CODON AFTER RESIDUE 212. VSC 280 2 VSC VSC 280 A WAT 1 3 HOH HOH 281 A WAT 2 3 HOH HOH 282 A WAT 3 3 HOH HOH 283 A WAT 4 3 HOH HOH 284 A WAT 5 3 HOH HOH 285 A WAT 6 3 HOH HOH 286 A WAT 7 3 HOH HOH 287 A WAT 8 3 HOH HOH 288 A WAT 9 3 HOH HOH 289 A WAT 10 3 HOH HOH 290 A WAT 11 3 HOH HOH 291 A WAT 12 3 HOH HOH 292 A WAT 13 3 HOH HOH 293 A WAT 14 3 HOH HOH 294 A WAT 15 3 HOH HOH 295 A WAT 16 3 HOH HOH 296 A WAT 17 3 HOH HOH 297 A WAT 18 3 HOH HOH 298 A WAT 19 3 HOH HOH 299 A WAT 20 3 HOH HOH 300 A WAT 21 3 HOH HOH 301 A WAT 22 3 HOH HOH 302 A WAT 23 3 HOH HOH 303 A WAT 24 3 HOH HOH 304 A WAT 25 3 HOH HOH 305 A WAT 26 3 HOH HOH 306 A WAT 27 3 HOH HOH 307 A WAT 28 3 HOH HOH 308 A WAT 29 3 HOH HOH 309 A WAT 30 3 HOH HOH 310 A WAT 31 3 HOH HOH 311 A WAT 32 3 HOH HOH 312 A WAT 33 3 HOH HOH 313 A WAT 34 3 HOH HOH 314 A WAT 35 3 HOH HOH 315 A WAT 36 3 HOH HOH 316 A WAT 37 3 HOH HOH 317 A WAT 38 3 HOH HOH 318 A ALA 1 n 1 ALA 1 A PRO 2 n 2 PRO 2 A ALA 3 n 3 ALA 3 A ALA 4 n 4 ALA 4 A VAL 5 n 5 VAL 5 A ASP 6 n 6 ASP 6 A TRP 7 n 7 TRP 7 A ARG 8 n 8 ARG 8 A ALA 9 n 9 ALA 9 A ARG 10 n 10 ARG 10 A GLY 11 n 11 GLY 11 A ALA 12 n 12 ALA 12 A VAL 13 n 13 VAL 13 A THR 14 n 14 THR 14 A ALA 15 n 15 ALA 15 A VAL 16 n 16 VAL 16 A LYS 17 n 17 LYS 17 A ASP 18 n 18 ASP 18 A GLN 19 n 19 GLN 19 A GLY 20 n 20 GLY 20 A GLN 21 n 21 GLN 21 A CYS 22 n 22 CYS 22 A GLY 23 n 23 GLY 23 A SER 24 n 24 SER 24 A CYS 25 n 25 CYS 25 A TRP 26 n 26 TRP 26 A ALA 27 n 27 ALA 27 A PHE 28 n 28 PHE 28 A SER 29 n 29 SER 29 A ALA 30 n 30 ALA 30 A ILE 31 n 31 ILE 31 A GLY 32 n 32 GLY 32 A ASN 33 n 33 ASN 33 A VAL 34 n 34 VAL 34 A GLU 35 n 35 GLU 35 A CYS 36 n 36 CYS 36 A GLN 37 n 37 GLN 37 A TRP 38 n 38 TRP 38 A PHE 39 n 39 PHE 39 A LEU 40 n 40 LEU 40 A ALA 41 n 41 ALA 41 A GLY 42 n 42 GLY 42 A HIS 43 n 43 HIS 43 A PRO 44 n 44 PRO 44 A LEU 45 n 45 LEU 45 A THR 46 n 46 THR 46 A ASN 47 n 47 ASN 47 A LEU 48 n 48 LEU 48 A SER 49 n 49 SER 49 A GLU 50 n 50 GLU 50 A GLN 51 n 51 GLN 51 A MET 52 n 52 MET 52 A LEU 53 n 53 LEU 53 A VAL 54 n 54 VAL 54 A SER 55 n 55 SER 55 A CYS 56 n 56 CYS 56 A ASP 57 n 57 ASP 57 A LYS 58 n 58 LYS 58 A THR 59 n 59 THR 59 A ASP 60 n 60 ASP 60 A SER 61 n 61 SER 61 A GLY 62 n 62 GLY 62 A CYS 63 n 63 CYS 63 A SER 64 n 64 SER 64 A GLY 65 n 65 GLY 65 A GLY 66 n 66 GLY 66 A LEU 67 n 67 LEU 67 A MET 68 n 68 MET 68 A ASN 69 n 69 ASN 69 A ASN 70 n 70 ASN 70 A ALA 71 n 71 ALA 71 A PHE 72 n 72 PHE 72 A GLU 73 n 73 GLU 73 A TRP 74 n 74 TRP 74 A ILE 75 n 75 ILE 75 A VAL 76 n 76 VAL 76 A GLN 77 n 77 GLN 77 A GLU 78 n 78 GLU 78 A ASN 78 n 79 A ASN 78 A ASN 78 n 80 B ASN 78 A GLY 78 n 81 C GLY 78 A ALA 79 n 82 ALA 79 A VAL 80 n 83 VAL 80 A TYR 81 n 84 TYR 81 A THR 82 n 85 THR 82 A GLU 83 n 86 GLU 83 A ASP 84 n 87 ASP 84 A SER 85 n 88 SER 85 A TYR 86 n 89 TYR 86 A PRO 87 n 90 PRO 87 A TYR 88 n 91 TYR 88 A ALA 89 n 92 ALA 89 A SER 89 n 93 A SER 89 A GLY 89 n 94 B GLY 89 A GLU 89 n 95 C GLU 89 A GLY 90 n 96 GLY 90 A ILE 91 n 97 ILE 91 A SER 92 n 98 SER 92 A PRO 93 n 99 PRO 93 A PRO 94 n 100 PRO 94 A CYS 95 n 101 CYS 95 A THR 96 n 102 THR 96 A THR 97 n 103 THR 97 A SER 98 n 104 SER 98 A GLY 99 n 105 GLY 99 A HIS 100 n 106 HIS 100 A THR 101 n 107 THR 101 A VAL 102 n 108 VAL 102 A GLY 103 n 109 GLY 103 A ALA 105 n 110 ALA 105 A THR 106 n 111 THR 106 A ILE 107 n 112 ILE 107 A THR 108 n 113 THR 108 A GLY 109 n 114 GLY 109 A HIS 110 n 115 HIS 110 A VAL 111 n 116 VAL 111 A GLU 112 n 117 GLU 112 A LEU 113 n 118 LEU 113 A PRO 114 n 119 PRO 114 A GLN 115 n 120 GLN 115 A ASP 116 n 121 ASP 116 A GLU 117 n 122 GLU 117 A ALA 118 n 123 ALA 118 A GLN 119 n 124 GLN 119 A ILE 120 n 125 ILE 120 A ALA 121 n 126 ALA 121 A ALA 122 n 127 ALA 122 A TRP 123 n 128 TRP 123 A LEU 124 n 129 LEU 124 A ALA 125 n 130 ALA 125 A VAL 126 n 131 VAL 126 A ASN 127 n 132 ASN 127 A GLY 128 n 133 GLY 128 A PRO 129 n 134 PRO 129 A VAL 130 n 135 VAL 130 A ALA 131 n 136 ALA 131 A VAL 132 n 137 VAL 132 A ALA 133 n 138 ALA 133 A VAL 134 n 139 VAL 134 A ASP 135 n 140 ASP 135 A ALA 136 n 141 ALA 136 A SER 139 n 142 SER 139 A SER 140 n 143 SER 140 A TRP 141 n 144 TRP 141 A MET 142 n 145 MET 142 A THR 143 n 146 THR 143 A TYR 144 n 147 TYR 144 A THR 145 n 148 THR 145 A GLY 146 n 149 GLY 146 A GLY 147 n 150 GLY 147 A VAL 148 n 151 VAL 148 A MET 149 n 152 MET 149 A THR 151 n 153 THR 151 A SER 152 n 154 SER 152 A CYS 153 n 155 CYS 153 A VAL 154 n 156 VAL 154 A SER 155 n 157 SER 155 A GLU 156 n 158 GLU 156 A GLN 156 n 159 A GLN 156 A LEU 157 n 160 LEU 157 A ASP 158 n 161 ASP 158 A HIS 159 n 162 HIS 159 A GLY 160 n 163 GLY 160 A VAL 161 n 164 VAL 161 A LEU 162 n 165 LEU 162 A LEU 163 n 166 LEU 163 A VAL 164 n 167 VAL 164 A GLY 165 n 168 GLY 165 A TYR 166 n 169 TYR 166 A ASN 167 n 170 ASN 167 A ASP 167 n 171 A ASP 167 A SER 167 n 172 B SER 167 A ALA 167 n 173 C ALA 167 A ALA 167 n 174 D ALA 167 A VAL 168 n 175 VAL 168 A PRO 169 n 176 PRO 169 A TYR 170 n 177 TYR 170 A TRP 171 n 178 TRP 171 A ILE 172 n 179 ILE 172 A ILE 173 n 180 ILE 173 A LYS 174 n 181 LYS 174 A ASN 175 n 182 ASN 175 A SER 176 n 183 SER 176 A TRP 177 n 184 TRP 177 A THR 178 n 185 THR 178 A THR 179 n 186 THR 179 A GLN 180 n 187 GLN 180 A TRP 181 n 188 TRP 181 A GLY 182 n 189 GLY 182 A GLU 183 n 190 GLU 183 A GLU 184 n 191 GLU 184 A GLY 185 n 192 GLY 185 A TYR 186 n 193 TYR 186 A ILE 187 n 194 ILE 187 A ARG 188 n 195 ARG 188 A ILE 189 n 196 ILE 189 A ALA 190 n 197 ALA 190 A LYS 191 n 198 LYS 191 A GLY 192 n 199 GLY 192 A SER 193 n 200 SER 193 A ASN 198 n 201 ASN 198 A GLN 199 n 202 GLN 199 A CYS 200 n 203 CYS 200 A LEU 201 n 204 LEU 201 A VAL 202 n 205 VAL 202 A LYS 203 n 206 LYS 203 A GLU 204 n 207 GLU 204 A GLU 205 n 208 GLU 205 A ALA 206 n 209 ALA 206 A SER 207 n 210 SER 207 A SER 208 n 211 SER 208 A ALA 209 n 212 ALA 209 A VAL 210 n 213 VAL 210 A VAL 211 n 214 VAL 211 A GLY 212 n 215 GLY 212 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 111 A N VAL 116 A O SER 208 A O SER 211 A O SER 207 A O SER 210 A N ALA 131 A N ALA 136 A N VAL 134 A N VAL 139 A O HIS 159 A O HIS 162 A O TYR 166 A O TYR 169 A N VAL 5 A N VAL 5 A N VAL 111 A N VAL 116 A O SER 208 A O SER 211 A O SER 207 A O SER 210 A N ALA 131 A N ALA 136 A N VAL 134 A N VAL 139 A O HIS 159 A O HIS 162 A N ASN 167 A N ASN 170 A O TYR 170 A O TYR 177 A N ILE 173 A N ILE 180 A O ILE 187 A O ILE 194 A O ARG 188 A O ARG 195 A N MET 149 A N MET 152 A O VAL 80 A O VAL 83 A N GLY 103 A N GLY 109 1 A C36 VSC 280 B C36 VSC 1 1 N 1 A C37 VSC 280 B C37 VSC 1 1 N 1 A C38 VSC 280 B C38 VSC 1 1 N 1 A C39 VSC 280 B C39 VSC 1 1 N 1 A C40 VSC 280 B C40 VSC 1 1 N 1 A C41 VSC 280 B C41 VSC 1 1 N 1 A ASP 57 -68.81 94.96 1 A ALA 89 -141.44 28.59 1 A SER 155 -118.55 79.19 1 A GLU 156 -121.31 -54.50 1 A ASP 158 -150.55 7.77 1 A THR 178 74.63 162.15 1 A CYS 200 59.33 18.66 PARHCSDX.PRO TOPHCSDX.PRO PARAM19.SOL TOPH19.SOL VSC.TPX VSC_VER2.TPX 19.9 0.00 0.00 0.00 0.00 0.00 0.00 parameters for VSC from moloc 0.262 0.008 0.221 0.23 0.221 2.10 30.00 1033 10544 10544 9.8 95.0 RANDOM 10000000.00 0.00 1 RESTRAINED THROUGHOUT 0.0 0 Engh & Huber 0.34 0.28 5.00 0.40 0.32 2.10 30.00 38 1668 37 0 1593 0.005 1.2 25.0 1.04 0.355 0.028 0.298 2.23 166 1522 6 9.8 91.9 7.2 2.1 30 1EWO 10544 10544 0 -3.0 0.077 1 7.2 2.1 92.2 0.197 2.10 2.18 997 1 2.1 90.6 data reduction DENZO data scaling SCALEPACK phasing AMoRE refinement X-PLOR 3.843 CRUZAIN (E.C.3.4.22.-) THE CYSTEINE PROTEASE CRUZAIN BOUND TO WRR-204 1 N N 2 N N 3 N N A ARG 8 A ARG 8 HELX_P A GLY 11 A GLY 11 5 1 4 A SER 24 A SER 24 HELX_P A ALA 41 A ALA 41 1 2 18 A SER 49 A SER 49 HELX_P A ASP 57 A ASP 57 1 3 9 A SER 61 A SER 61 HELX_P A GLY 65 A GLY 65 5 4 5 A ASP 116 A ASP 121 HELX_P A GLY 128 A GLY 133 1 6 13 A ALA 136 A ALA 141 HELX_P A TYR 144 A TYR 147 5 7 7 A ASN 198 A ASN 201 HELX_P A VAL 202 A VAL 205 5 8 5 disulf 2.029 A CYS 22 A SG CYS 22 1_555 A CYS 63 A SG CYS 63 1_555 disulf 2.028 A CYS 56 A SG CYS 56 1_555 A CYS 95 A SG CYS 101 1_555 disulf 2.029 A CYS 153 A SG CYS 155 1_555 A CYS 200 A SG CYS 203 1_555 covale 1.823 A CYS 25 A SG CYS 25 1_555 A VSC 280 B C32 VSC 1_555 HYDROLASE/HYDROLASE INHIBITOR cysteine protease, drug design, covalent inhibitor, cruzipain, HYDROLASE-HYDROLASE INHIBITOR COMPLEX CYSP_TRYCR UNP 1 123 P25779 APAAVDWRARGAVTAVKDQGQCGSCWAFSAIGNVECQWFLAGHPLTNLSEQMLVSCDKTDSGCSGGLMNNAFEWIVQENN GAVYTEDSYPYASGEGISPPCTTSGHTVGATITGHVELPQDEAQIAAWLAVNGPVAVAVDASSWMTYTGGVMTSCVSEQL DHGVLLVGYNDSAAVPYWIIKNSWTTQWGEEGYIRIAKGSNQCLVKEEASSAVVG 123 337 1EWO 1 212 P25779 A 1 1 215 5 7 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel A GLY 109 A GLY 114 A GLU 112 A GLU 117 A ALA 206 A ALA 209 A VAL 210 A VAL 213 A VAL 130 A VAL 135 A VAL 134 A VAL 139 A HIS 159 A HIS 162 A ASN 167 A ASN 170 A ALA 4 A ALA 4 A ASP 6 A ASP 6 A GLY 109 A GLY 114 A GLU 112 A GLU 117 A ALA 206 A ALA 209 A VAL 210 A VAL 213 A VAL 130 A VAL 135 A VAL 134 A VAL 139 A HIS 159 A HIS 162 A ASN 167 A ASN 170 A TYR 170 A TYR 177 A LYS 174 A LYS 181 A TYR 186 A TYR 193 A ALA 190 A ALA 197 A VAL 148 A VAL 151 A MET 149 A MET 152 A ALA 79 A ALA 82 A TYR 81 A TYR 84 A VAL 102 A VAL 108 A THR 106 A THR 111 BINDING SITE FOR RESIDUE VSC A 280 Software 12 A GLN 19 A GLN 19 12 1_555 A GLY 23 A GLY 23 12 1_555 A CYS 25 A CYS 25 12 1_555 A TRP 26 A TRP 26 12 1_555 A SER 61 A SER 61 12 1_555 A CYS 63 A CYS 63 12 1_555 A GLY 65 A GLY 65 12 1_555 A GLY 66 A GLY 66 12 1_555 A ALA 133 A ALA 138 12 1_555 A ASP 158 A ASP 161 12 1_555 A HIS 159 A HIS 162 12 1_555 A TRP 177 A TRP 184 12 1_555 4 P 1 21 1